Valeant Pharmaceuticals International, Inc. announced that Laizer D. Kornwasser has been named to company's Executive Management Team and will assume the role of Executive Vice President/Company Group Chairman where he will be responsible for its operations in Canada, U.S. Neurology and various other U.S. functions including managed care and distribution, effective February 1, 2013. Laizer D. Kornwasser was a Senior Executive at Medco Health prior to its acquisition by Express Scripts. At Medco he reported directly into the CEO and was a member of Executive Committee.

He served as Senior Vice President, Consumer Solutions and Retail Markets and was responsible for retail network and mail pharmacy products and strategy. He oversaw network pricing, negotiations, plan designs and programs that maximized the retail and mail channels. Mr. Kornwasser was also responsible for the integrated care solution for Medco's six million members with diabetes.

Mr. Kornwasser joined Medco in August 2003, and was initially responsible for building a business development team, post spin-off from Merck. In this role he oversaw all acquisitions, joint ventures and was actively involved in developing the company's long-term growth strategy. He later assumed responsibility for the companies' channel and generic drug strategy and was President of its diabetes division, which focused on direct to consumer solutions.

Prior to joining Medco, Mr. Kornwasser held positions at Merrill Lynch and Coopers & Lybrand.